Previous reports have warned about the influence of spinal cord injury (SCI) on the pharmacokinetics of various drugs. However, the role of SCI in the efficacy and safety of pharmacotherapy remains unknown. Thereby, our aim was to explore the role of SCI on pharmacokinetics and anti-inflammatory effect of naproxen in response to a local inflammatory challenge. Rats received a severe contusive SCI at T9 or sham injury. Pharmacokinetics of a single intravenous dose of naproxen (10 mg kg−1) was studied at days 1 and 15 post-surgery. For the anti-inflammatory assessment, carrageenan was subcutaneously injected in forelimb and hindlimb paws at the same post-surgery periods, and naproxen efficacy was evaluated measuring paw swelling. Plasma protein concentrations and body weight changes were also determined. Plasma naproxen levels and pharmacokinetic parameters were unchanged by acute injury, but subacute injury generated alterations in volume of distribution, clearance, and bioavailability, resulting in significantly reduced plasma naproxen concentrations, in the absence of changes in plasma proteins. Assessment of naproxen anti-inflammatory activity during the acute stage of injury could not be determined because of carrageenan failure to elicit swelling. During the subacute stage, naproxen anti-inflammatory effect on forelimbs (above injury) was similar to that observed in sham-injured animals, while it was almost absent in paralyzed hindlimbs. Under conditions of SCI and peripheral inflammation, pharmacokinetics and anti-inflammatory activity of naproxen vary according to post-injury timing and neurological status of the assessed region.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Adachi K, Yimin Y, Satake K, Matsuyama Y, Ishiguro N, Sawada M, Hirata Y, Kiuchi K (2005) Localization of cyclooxygenase-2 induced following traumatic spinal cord injury. Neurosci Res 51:73–80. https://doi.org/10.1016/j.neures.2004.10.007
Chandra J, Sheerin F, Lopez de Heredia L, Meagher T, King D, Belci M, Hughes RJ (2012) MRI in acute and subacute post-traumatic spinal cord injury: pictorial review. Spinal Cord 50:2–7. https://doi.org/10.1038/sc.2011.107
Cruz-Antonio L, Flores-Murrieta FJ, García-Lopez P, Guizar-Sahagun G, Castañeda-Hernández G (2006) Understanding drug disposition alterations induced by acute spinal cord injury: role of injury level and route of administration for agents submitted to extensive liver metabolism. J Neurotrauma 23:75–85. https://doi.org/10.1089/neu.2006.23.75
Cruz-Antonio L, Arauz J, Franco-Bourland RE, Guizar-Sahagun G, Castaneda-Hernandez G (2012) Contrasting effects of cord injury on intravenous and oral pharmacokinetics of diclofenac: a drug with intermediate hepatic extraction. Spinal Cord 50:632–635. https://doi.org/10.1038/sc.2012.20
Cuzzocrea S, Zingarelli B, Hake P, Salzman AL, Szabo C (1998) Antiinflammatory effects of mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, in carrageenan-induced models of inflammation. Free Radic Biol Med 24:450–459. https://doi.org/10.1016/S0891-5849(97)00280-3
Deitrick G, Charalel J, Bauman W, Tuckman J (2007) Reduced arterial circulation to the legs in spinal cord injury as a cause of skin breakdown lesions. Angiology 58:175–184. https://doi.org/10.1177/0003319707300353
Ditunno J, Little J, Tessler A, Burns A (2004) Spinal shock revisited: a four-phase model. Spinal Cord 42:383–395. https://doi.org/10.1038/sj.sc.3101603
Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, Marnett LJ (2010) Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen. J Biol Chem 285:34950–34959. https://doi.org/10.1074/jbc.M110.162982
Garcia-Lopez P, Martinez-Cruz A, Guizar-Sahagun G, Castaneda-Hernandez G (2007) Acute spinal cord injury changes the disposition of some, but not all drugs given intravenously. Spinal Cord 45:603–608. https://doi.org/10.1038/sj.sc.3102001
Guay J, Bateman K, Gordon R, Mancini J, Riendeau D (2004) Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem 279:24866–24872. https://doi.org/10.1074/jbc.M403106200
Guizar-Sahagun G, Castaneda-Hernandez G, Garcia-Lopez P, Franco-Bourland R, Grijalva I, Madrazo I (1998) Pathophysiological mechanisms involved in systemic and metabolic alterations secondary to spinal cord injury. Proc West Pharmacol Soc 41:237–240
Guizar-Sahagun G, Velasco-Hernandez L, Martinez-Cruz A, Castaneda-Hernandez G, Bravo G, Rojas G et al (2004) Systemic microcirculation after complete high and low thoracic spinal cord section in rats. J Neurotrauma 21:1614–1623. https://doi.org/10.1089/neu.2004.21.1614
Hardman JG, Limbird LE (2003) Goodman and Gilman’s the pharmacological basis of therapeutics. US, New York
Kruger NJ (2009) The Bradford method for protein quantitation. In: Walker JM (ed) The protein protocols handbook, Springer Protocols Handbooks. Humana Press, Totowa, pp 17–24
Lizarraga I, Chambers JP (2006) Involvement of opioidergic and alpha2-adrenergic mechanisms in the central analgesic effects of non-steroidal anti-inflammatory drugs in sheep. Res Vet Sci 80:194–200. https://doi.org/10.1016/j.rvsc.2005.06.001
Mazario J, Gaitan G, Herrero JF (2001) Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes. Neuropharmacology 40:937–946. https://doi.org/10.1016/S0028-3908(01)00020-X
Posadas I, Bucci M, Roviezzo F, Rossi A, Parente L, Sautebin L, Cirino G (2004) Carrageenan-induced mouse paw oedema is biphasic, age-weight dependent and displays differential nitric oxide cyclooxygenase-2 expression. Br J Pharmacol 142:331–338. https://doi.org/10.1038/sj.bjp.0705650
Quan HH, Kang KS, Sohn YK, Li M (2013) Tempol reduces injury area in rat model of spinal cord contusion injury through suppression of iNOS and COX-2 expression. Neurol Sci 34:1621–1628. https://doi.org/10.1007/s10072-013-1295-y
Rodriguez-Cal y Mayor A, Cruz-Antonio L, Castaneda-Hernandez G, Favari-Perozzi L, Guizar-Sahagun G (2018) Time-dependent changes in paw carrageenan-induced inflammation above and below the level of low thoracic spinal cord injury in rats. Spinal Cord 56:964–970. https://doi.org/10.1038/s41393-018-0144-5
Runkel R, Chaplin M, Boost G, Segre E, Forchielli E (1972) Absorption, distribution, metabolism, and excretion of naproxen in various laboratory animals and human subjects. J Pharm Sci 61:703–708. https://doi.org/10.1002/jps.2600610507
Schwab JM, Brechtel K, Nguyen TD, Schluesener HJ (2000) Persistent accumulation of cyclooxygenase-1 (COX-1) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J Neuroimmunol 111:122–130. https://doi.org/10.1016/S0165-5728(00)00372-6
Southall MD, Michael RL, Vasko MR (1998) Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from rat spinal cord slices. Pain 78:39–48. https://doi.org/10.1016/S0304-3959(98)00113-4
Sun X, Jones ZB, Chen XM, Zhou L, So KF, Ren Y (2016) Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation 13:260. https://doi.org/10.1186/s12974-016-0736-y
Tacconelli S, Bruno A, Grande R, Ballerini P, Patrignani P (2017) Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts. Expert Opin Drug Saf 16:791–807. https://doi.org/10.1080/14740338.2017.1338272
Tator CH, Fehlings MG (1991) Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 75:15–26. https://doi.org/10.3171/jns.1991.75.1.0015
Vanegas H, Schaible HG (2001) Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord. Prog Neurobiol 64:327–363. https://doi.org/10.1016/S0301-0082(00)00063-0
Vanegas H, Vazquez E, Tortorici V (2010) NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System. Pharmaceuticals (Basel) 3:1335–1347. https://doi.org/10.3390/ph3051335
Vazquez E, Escobar W, Ramirez K, Vanegas H (2007) A nonopioid analgesic acts upon the PAG-RVM axis to reverse inflammatory hyperalgesia. Eur J Neurosci 25:471–479. https://doi.org/10.1111/j.1460-9568.2007.05280.x
AR-C received a fellowship grant (number 378379) from the National Council for Science and Technology (CONACYT, http://www.conacyt.mx/pci/index.php) to support her doctoral studies.
All applicable international, national, and institutional guidelines for the care and use of animals were followed. The Ethics Committee in Research of the Instituto Mexicano del Seguro Social approved this study (file number: R-2015-3601-203). All efforts were made to minimize animal suffering and to reduce the number of animals used.
Conflict of interest
The authors declare that they have no conflict of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Rodríguez-Cal y Mayor, A., Castañeda-Hernández, G., Favari, L. et al. Pharmacokinetics and anti-inflammatory effect of naproxen in rats with acute and subacute spinal cord injury. Naunyn-Schmiedeberg's Arch Pharmacol 393, 395–404 (2020). https://doi.org/10.1007/s00210-019-01745-9
- Neurological status
- Peripheral inflammation